StevenKRoweMD

Cardiology • Key West, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to view full profile

Dr. Rowe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rowe's full profile

Already have an account?

Office
3428 N Roosevelt Blvd
Key West, FL 33040
Phone+1 305-294-5727

Fax+1 305-294-1506

Education & Training

Baylor College of MedicineFellowship, Cardiovascular Disease, 1987 - 1990
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1984 - 1987
University of Missouri-Columbia School of MedicineClass of 1984

Certifications & Licensure

FL State Medical License 2003 - 2026
MO State Medical License 1984 - 2025
KS State Medical License 1990 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction Start of enrollment: 2011 Mar 01
Recruiting
Phase 3
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral Start of enrollment: 2009 Aug 04
Terminated
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Start of enrollment: 2011 Aug 01
Suspended
Not Applicable

Publications & Presentations

PubMed

129 citations
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.
Sherif F. Nagueh, Bertron M. Groves, Leonard Schwartz, Karen M. Smith, Andrew Wang
Journal of the American College of Cardiology. 2011-11-22
17 citations
One-Year Outcomes in “Real-World” Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study ...
David E. Kandzari, Nima Amjadi, Christopher Caputo, Steven K. Rowe, Jerome Williams
The American Journal of Cardiology. 2016-02-15
3 citations
Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Stu...
David E. Kandzari, Nima Amjadi, Christopher Caputo, Steven K. Rowe, Henry Chen
The American Journal of Cardiology. 2019-06-01

Professional Memberships

American College of Cardiology - ACC
Member